Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Professor Alan Boddy
Newcastle Authors
Title
Year
Full text
Professor Gareth Veal
Julieann Sludden
Dr David Jamieson
Julie Errington
Dr Ghada Malik
et al.
Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin’s lymphoma
2016
Chris Walsh
Dr Jennifer Bonner
Professor Alan Boddy
Professor Gareth Veal
Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer
2016
Dr Nicola Cresti
Dr Despina Televantou
Dr David Jamieson
Dr Mark Verrill
Professor Alan Boddy
Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cance
2016
Barry Dent
Laura Ogle
Dr Rachel O'Donnell
Dr Ujjal Mallick
Professor Nicola Curtin
et al.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
2016
Dr Yvette Drew
Dr Martin Highley
Julieann Sludden
Dr James Murray
Dr David Jamieson
et al.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly (ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
2016
Professor Andrew Pearson
Dr Quentin Campbell Hewson
Professor Alan Boddy
Melanie Griffin
A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study
2015
Professor Alan Boddy
Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer
2015
Dr James Murray
Julieann Sludden
Professor Alan Boddy
Professor Nicola Curtin
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
2015
Professor Alan Boddy
Age dependence of doxorubicin pharmacokinetics in pediatric cancer patients; results of an FP7-funded clinical study
2014
Dr Anthony Oxley
Philip Berry
Gordon Taylor
Dr Joe Cowell
Dr Michael Hall
et al.
An LC/MS/MS method for stable isotope dilution studies of β-carotene bioavailability, bioconversion and vitamin A status in humans
2014
Dr Chris Hill
Julie Errington
Dr Ghada Malik
Professor Alan Boddy
Professor Gareth Veal
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer
2014
Barry Dent
Dr Rachel O'Donnell
Laura Ogle
Padmini Ramesh
Nick Hayes
et al.
Detection and characterization of circulating tumor cells by imaging flow cytometry
2014
Dr David Jamieson
Dr Jo Lee
Dr Nicola Cresti
Melanie Griffin
Julieann Sludden
et al.
Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil
2014
Dr Hyun Jin Park
Professor Georg Lietz
Dr Anthony Oxley
Professor Alan Boddy
Philip Berry
Simplified approaches for estimating vitamin A stores and β-carotene bioconversion in humans
2014
Professor Alan Boddy
Sources of preanalytical error in pharmacokinetic analyses - focus on intravenous drug administration and collection of blood samples
2014
1
2
3
4
5
6
7
8
9
10
11
12